PAT-505

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NamePAT-505

Drug Alias NamePAT-505

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors

TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2

Therapy Area/IndicationsLiver Cirrhosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharmakea Inc

China Registration ClassN/A

Active CompaniesPharmakea Inc

Inactive CompaniesN/A

Active IndicationsLiver Cirrhosis

Inactive IndicationsN/A

ATC CodeN/A